Low-Dose Decitabine Plus Venetoclax Maintenance Therapy Can Decrease the Relapse after Allogeneic Stem Cell Transplantation for MRD Positive High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Category Primary study
JournalBlood
Year 2020
This article has no abstract
Epistemonikos ID: f3ad0d5bf936ee9094faa86b292a413a6542bfa5
First added on: Feb 12, 2025